UnknownNCT05949424
OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults
PHASE4 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- November 29, 2023
immortal.lifeTrial registrations containing the exact intervention label Pazopanib.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE4 · 30 planned enrolment
PHASE1 · 15 planned enrolment